` 0AB6 (Hyloris Pharmaceuticals SA) vs DAX Index Comparison - Alpha Spread

0AB6
vs
D
DAX Index

Over the past 12 months, 0AB6 has underperformed DAX Index, delivering a return of +2% compared to the DAX Index's +5% growth.

Stocks Performance
0AB6 vs DAX Index

Loading
0AB6
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
0AB6 vs DAX Index

Loading
0AB6
DAX Index
Difference
www.alphaspread.com

Performance By Year
0AB6 vs DAX Index

Loading
0AB6
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Hyloris Pharmaceuticals SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Hyloris Pharmaceuticals SA
Glance View

Market Cap
1.8m EUR
Industry
Pharmaceuticals

Hyloris Pharmaceuticals SA engages in the development and reformulating of pharmaceutical products. The company is headquartered in Liege, Liege and currently employs 14 full-time employees. The company went IPO on 2020-06-29. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.

0AB6 Intrinsic Value
18.44 EUR
Undervaluation 63%
Intrinsic Value
Price
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett